Family Medicine · Gulfport, MS
NPI
1982719779
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
394 Courthouse Rd, Suite A
Gulfport, MS, 39507
Phone (228) 896-4417
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
1,728 services
Medicare patients, 2024
260
Average age 74
Drug cost, 2024
$1.4M
12,081 prescriptions
Company payments, 2025
$1,234
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven Schepens was code 99214 (office e&m - established), 541 times for 242 patients. In total Steven Schepens billed 1,728 services in 22 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 541 | 242 | $62.34 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 440 | 227 | $11.01 | $4,845 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 173 | 38 | $35.82 | $6,197 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 144 | 144 | $117.39 | $17K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 143 | 143 | $8.34 | $1,192 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 125 | 125 | $8.33 | $1,042 |
| 99497 Care Management/Coordination | Office | 80 | 80 | $68.08 | $5,446 |
| 99213 Office E&M - Established | Office | 25 | 22 | $38.82 | $970 |
By year: 2022 $58K for 1,053 services; 2023 $60K for 1,119 services; 2024 $74K for 1,728 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven Schepens prescribed most often to Medicare patients was Levothyroxine Sodium, with 648 prescriptions and refills. In total Steven Schepens wrote 12,081 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 648 | 1,026 | 105 | $7,704 |
| Omeprazole Generic | 463 | 704 | 68 | $4,845 |
| Atorvastatin Calcium Generic | 386 | 762 | 83 | $4,011 |
| Pantoprazole Sodium Generic | 385 | 627 | 70 | $4,023 |
| Rosuvastatin Calcium Generic | 362 | 872 | 102 | $5,743 |
| Losartan Potassium Generic | 359 | 715 | 77 | $2,838 |
| Amlodipine Besylate Generic | 353 | 745 | 86 | $1,870 |
| Clonidine Hcl Generic | 323 | 375 | 38 | $2,289 |
| Lorazepam Generic | 239 | 240 | 63 | $1,983 |
| Hydrochlorothiazide Generic | 226 | 440 | 47 | $840 |
| Montelukast Sodium Generic | 181 | 321 | 34 | $2,135 |
| Famotidine Generic | 176 | 237 | 25 | $1,697 |
| Metformin Hcl Generic | 171 | 392 | 42 | $731 |
| Potassium Chloride Generic | 170 | 312 | 37 | $10K |
| Risperidone Generic | 167 | 173 | 17 | $2,172 |
Brand drugs: 1,313 claims; generic drugs: 10,696 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Schepens $1,234 ($1,234 in general payments such as food, travel and fees) from 15 companies. The largest payer was Novo Nordisk Inc with $249.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 12 | $249 |
| Abbvie Inc. ABBV | 14 | $242 |
| Lilly USA, LLC LLY | 11 | $178 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $112 |
| Pfizer Inc. PFE | 5 | $92.17 |
| GlaxoSmithKline, LLC. GSK | 4 | $65.89 |
| Amgen Inc. AMGN | 3 | $52.97 |
| Merck Sharp & Dohme LLC MRK | 2 | $45.58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $42.44 |
| Lundbeck LLC | 1 | $38.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.